Actinic Porokeratosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-12-07
Clinical Trial Update: DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone [Phase 1]
Phase 1 trial comparing 2% Lovastatin/2% Cholesterol versus 2% Lovastatin alone for actinic porokeratosis; study completed with results post…